(Reuters) - The move had been expected following approval from a panel of European experts in March. Recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use are normally endorsed by the EU within 90 days.
The New York-based drugmaker said in November Orencia, given by intravenous infusion, had proved superior in effectiveness after six months to placebo in a clinical trial.
Read more at Reuters.com Government Filings News
The New York-based drugmaker said in November Orencia, given by intravenous infusion, had proved superior in effectiveness after six months to placebo in a clinical trial.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment